Surgical treatment of intracranial malignant melanoma: an anlysis of 7 cases / 中华神经医学杂志

ABSTRACT

Objective:To explore the surgical treatment efficacy and experience of intracranial malignant melanoma (IMM).Methods:Seven patients with IMM, including 3 with primary IMM and 4 with secondary IMM, admitted to our hospital from May 2013 to June 2018, were treated with minimally invasive transcranial surgery. The tumors were removed as much as possible during the operation; according to the postoperative condition of these patients, adjuvant therapies such as follow-up or radiotherapy/chemotherapy, or/and reoperation/comprehensive treatment were provided.Results:These 7 patients eventually died; among the 3 patients with primary IMM, one had total resection, one had subtotal resection, and one had partial resection, and the postoperative survival period was 10 months, 7 months and one month, respectively; among the 4 patients with secondary IMM, three had total resection, and one had partial resection, and the postoperative survival period was 32 months, 13 months, 12 months and 5 month, respectively.Conclusion:The overall prognosis of IMM patients is poor, and surgical removal of the primary and intracranial lesions is the key to prolong survival.